The complication rate following Neodymium-doped Yttrium Aluminum Garnet laser posterior capsulotomy for posterior capsular opacification in patients with and without comorbidities.

Intraocular lens neodymium-doped yttrium aluminum garnet laser phacoemulsification posterior capsular opacification

Journal

Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376

Informations de publication

Date de publication:
03 2023
Historique:
entrez: 6 3 2023
pubmed: 7 3 2023
medline: 8 3 2023
Statut: ppublish

Résumé

To study the complication rate following Nd: YAG posterior capsulotomy posterior capsular opacification (PCO) in patients with and without comorbid conditions. This was a prospective, interventional, comparative, and observational study. A total of 80 eyes, consisting of 40 eyes without ocular comorbidities (group A) and 40 eyes with ocular comorbidities (group B) that were being treated with Nd: YAG capsulotomy for PCO, were included. Visual outcome and complications of Nd: YAG capsulotomy were studied. The mean age of group A patients was 61.65 ± 8.85 years and that of group B patients was 63 ± 10.46 years. Of the total, 38 (47.5%) were men and 42 (52.5%) were women. In group B, the ocular comorbidities were moderate nonproliferative diabetic retinopathy (NPDR) (n = 14 eyes; 14/40 = 35%), subluxated intraocular lens (IOL; <2 clock hours of subluxation; n = 6), age-related macular degeneration (ARMD; n = 6), post-uveitic eyes (having old signs of uveitis, no episode of uveitis since the last 1 year; n = 5), and operated cases of traumatic cataract (n = 4). The mean energy required in groups A and B was 46.95 ± 25.92 and 42.62 ± 21.85 mJ, respectively (P = 0.422). The average energy requirement in Grade 2, Grade 3, and Grade 4 PCO was 22.30, 41.62, and 79.52 mJ, respectively. An increase in intraocular pressure (IOP) of >5 mmHg from pre-YAG levels was observed in one patient in each group on day 1 postprocedure, for which medical treatment was given to both patients for 7 days. One patient in each group had IOL pitting. No patient had any other complications attributable to ND:YAG capsulotomy. Nd:YAG laser posterior capsulotomy is a safe procedure for PCO in patients with comorbidities. Visual outcomes were excellent after Nd:YAG posterior capsulotomy. Although a transient increase in IOP was noted, the response to treatment was good and a long-term increase in IOP was not observed.

Identifiants

pubmed: 36872680
pii: IndianJOphthalmol_2023_71_3_791_371067
doi: 10.4103/ijo.IJO_1885_22
pmc: PMC10229945
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

791-796

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Déclaration de conflit d'intérêts

None

Références

Arch Ophthalmol. 2000 Oct;118(10):1334-7
pubmed: 11030814
Nepal J Ophthalmol. 2012 Jan-Jun;4(1):108-13
pubmed: 22344007
J Cataract Refract Surg. 2001 Jul;27(7):1039-46
pubmed: 11489573
Cureus. 2021 Jul 7;13(7):e16242
pubmed: 34373805
Acta Med Croatica. 2006;60(2):109-12
pubmed: 16848199
Int Ophthalmol. 2017 Aug;37(4):1003-1008
pubmed: 27699606
Ophthalmic Surg Lasers Imaging. 2010 Jan-Feb;41(1):67-71
pubmed: 20143510
J Cataract Refract Surg. 2013 May;39(5):699-704
pubmed: 23499069
J Curr Glaucoma Pract. 2017 May-Aug;11(2):63-66
pubmed: 28924341
Ophthalmology. 1999 Jan;106(1):49-54; discussion 54-5
pubmed: 9917780
Arch Ophthalmol. 2009 Apr;127(4):555-62
pubmed: 19365040
Arq Bras Oftalmol. 2008 Sep-Oct;71(5):706-10
pubmed: 19039468
J Cataract Refract Surg. 2006 Oct;32(10):1627-31
pubmed: 17010858
J Cataract Refract Surg. 2000 Feb;26(2):180-7
pubmed: 10683785
Clin Ophthalmol. 2009;3:363-5
pubmed: 19668591
Eur J Ophthalmol. 2002 Sep-Oct;12(5):388-94
pubmed: 12474921
Am J Ophthalmol. 2012 Nov;154(5):808-813.e1
pubmed: 22958858
Ophthalmic Surg Lasers Imaging. 2012 Sep-Oct;43(5):395-400
pubmed: 22785102
Indian J Ophthalmol. 2004 Jun;52(2):99-112
pubmed: 15283214
BMC Ophthalmol. 2019 Feb 4;19(1):40
pubmed: 30717688
Indian J Ophthalmol. 2017 Dec;65(12):1440-1444
pubmed: 29208831
Arch Soc Esp Oftalmol. 2013 Nov;88(11):415-22
pubmed: 24157319
Eye (Lond). 1999 Jun;13 ( Pt 3b):489-92
pubmed: 10627830
Ophthalmology. 1985 Jul;92(7):973-6
pubmed: 4022582
J Ophthalmic Vis Res. 2015 Jan-Mar;10(1):37-42
pubmed: 26005551
Surv Ophthalmol. 1992 Sep-Oct;37(2):73-116
pubmed: 1455302
Indian J Ophthalmol. 2019 Sep;67(9):1428-1432
pubmed: 31436186
Med Hypothesis Discov Innov Ophthalmol. 2014 Summer;3(2):45-50
pubmed: 25738159

Auteurs

Rajesh S Joshi (RS)

Department of Ophthalmology, Government Medical College, Nagpur, Maharashtra, India.

Pallavi Doble (P)

Department of Ophthalmology, Government Medical College, Nagpur, Maharashtra, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH